Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intensive nutritional care for patients treated with radiotherapy in head and neck cancer: a randomized study and meta-analysis.
Roussel LM, Micault E, Peyronnet D, Blanchard D, Guarnieri S, Choussy O, Géry B, Béquignon A, Joubert C, Parienti JJ, Babin E. Roussel LM, et al. Among authors: gery b. Eur Arch Otorhinolaryngol. 2017 Feb;274(2):977-987. doi: 10.1007/s00405-016-4278-9. Epub 2016 Aug 27. Eur Arch Otorhinolaryngol. 2017. PMID: 27568350 Review.
[Oropharyngeal cancer].
Blanchard D, Rame JP, Louis MY, Gery B, Florescu C, de Raucourt D, Gervais R. Blanchard D, et al. Among authors: gery b. Bull Cancer. 2014 May 1;101(5):429-37. doi: 10.1684/bdc.2014.1957. Bull Cancer. 2014. PMID: 24886893 Review. French.
Retrospective evaluation of concomitant cetuximab and radiotherapy tolerance for locoregional advanced head and neck squamous cell carcinoma treatment in patients unfit for platinum-based chemotherapy.
Rambeau A, Gervais R, De Raucourt D, Babin E, Dugué AE, Florescu C, Blanchard D, Gery B. Rambeau A, et al. Among authors: gery b. Eur Arch Otorhinolaryngol. 2017 Jul;274(7):2883-2889. doi: 10.1007/s00405-017-4550-7. Epub 2017 Apr 5. Eur Arch Otorhinolaryngol. 2017. PMID: 28382396
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial.
Geoffrois L, Martin L, De Raucourt D, Sun XS, Tao Y, Maingon P, Buffet J, Pointreau Y, Sire C, Tuchais C, Babin E, Coutte A, Rolland F, Kaminsky MC, Alfonsi M, Lapeyre M, Saliou M, Lafond C, Jadaud E, Gery B, Zawadi A, Tourani JM, Khoury C, Henry AR, Hasbini A, Guichard F, Borel C, Meert N, Guillet P, Calais MH, Garaud P, Bourhis J. Geoffrois L, et al. Among authors: gery b. J Clin Oncol. 2018 Nov 1;36(31):3077-3083. doi: 10.1200/JCO.2017.76.2591. Epub 2018 Jul 17. J Clin Oncol. 2018. PMID: 30016178
28 results